Bone Marrow-Derived Mesenchymal Stem Cells Become Antiangiogenic When Chondrogenically or Osteogenically Differentiated: Implications for Bone and Cartilage Tissue Engineering
Restricted accessResearch articleFirst published online January, 2014
Bone Marrow-Derived Mesenchymal Stem Cells Become Antiangiogenic When Chondrogenically or Osteogenically Differentiated: Implications for Bone and Cartilage Tissue Engineering
Osteochondral tissue repair requires formation of vascularized bone and avascular cartilage. Mesenchymal stem cells stimulate angiogenesis both in vitro and in vivo but it is not known if these proangiogenic properties change as a result of chondrogenic or osteogenic differentiation. We investigated the angiogenic/antiangiogenic properties of equine bone marrow-derived mesenchymal stem cells (eBMSCs) before and after differentiation in vitro. Conditioned media from chondrogenic and osteogenic cell pellets and undifferentiated cells was applied to endothelial tube formation assays using Matrigel™. Additionally, the cell secretome was analysed using LC-MS/MS mass spectrometry and screened for angiogenesis and neurogenesis-related factors using protein arrays. Endothelial tube-like formation was supported by conditioned media from undifferentiated eBMSCs. Conversely, chondrogenic and osteogenic conditioned media was antiangiogenic as shown by significantly decreased length of endothelial tube-like structures and degree of branching compared to controls. Undifferentiated cells produced higher levels of angiogenesis-related proteins compared to chondrogenic and osteogenic pellets. In summary, eBMSCs produce an array of angiogenesis-related proteins and support angiogenesis in vitro via a paracrine mechanism. However, when these cells are differentiated chondrogenically or osteogenically, they produce a soluble factor(s) that inhibits angiogenesis. With respect to osteochondral tissue engineering, this may be beneficial for avascular articular cartilage formation but unfavourable for bone formation where a vascularized tissue is desired.
Get full access to this article
View all access options for this article.
References
1.
ReedA.A., JoynerC.J., IsefukuS., BrownlowH.C., and SimpsonA.H.Vascularity in a new model of atrophic nonunion. J Bone Joint Surg Br, 85-B, 604, 2003.
2.
BrownR.A., and WeissJ.B.Neovascularisation and its role in the osteoarthritic process. Ann Rheum Dis, 47, 881, 1988.
3.
WalshD.A.Angiogenesis in osteoarthritis and spondylosis: successful repair with undesirable outcomes. Curr Opin Rheumatol, 16, 609, 2004.
4.
BonnetC.S., and WalshD.A.Osteoarthritis, angiogenesis and inflammation. Rheumatology, 44, 7, 2005.
5.
RobertsS., McCallI.W., DarbyA.J., MenageJ., EvansH., HarrisionP.E., and RichardsonJ.B.Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology. Arthritis Res and Ther, 5, R60, 2003.
6.
O'SheaT.M., and MiaoX.Bilayered scaffolds for osteochondral tissue engineering. Tissue Eng Part B, 14, 4, 2008.
7.
Ishaug-RileyS.L., Crane-KrugerG.M., YaszemskiM.J., and MikosA.G.Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials, 19, 15, 1998.
8.
AltmannB., SteinbergT., GiselbrechtS., GottwaldE., TomakidiP., Bächle-HaasM., and KohalR.J.Promotion of osteoblast differentiation in 3D biomaterial micro-chip arrays comprising fibronectin-coated poly(methyl methacrylate) polycarbonate. Biomaterials, 32, 34, 2011.
9.
ZhaoJ., HanW., ChenH., TuM., HuanS., MiaoG., ZengR., WuH., ChaZ., and ZhouC.Fabrication and in vivo osteogenesis of biomimetic poly(propylene carbonate) scaffold with nanofibrous chitosan network in macropores for bone tissue engineering. J Mater Sci Mater Med, 23, 2, 2012.
10.
YuH., VandeVordP.J., GongW., WuB., SongZ., MatthewH.W., WooleyP.H., and YangS.Y.Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J Orthop Res, 26, 8, 2008.
11.
KoobS., Torio-PadronN., StarkB.G., HannigC., StankovicZ., and FinkenzellerG.Bone formation and neovascularisation mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng Part A, 17, 3, 2011.
12.
MurphyW.L., SimmonsC.A., KaiglerD., and MooneyD.J.Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res, 83, 3, 2004.
13.
KaiglerD., WangZ., HorgerK., MooneyD., and KrebsbachP.H.VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res, 21, 5, 2006.
14.
WarnkeP.H., SpringerI.N., WiltfangJ., AcilY., and EufingerH.Growth and transplantation of a custom vascularised bone graft in man. Lancet, 364, 9436, 2004.
15.
QuartoR., MastrogiacomoM., CanceddaR., KutepovS.M., MukhachevV., LavroukovA., KonE., and MarcacciM.Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med., 344, 5, 2001.
16.
MarcacciM., KonE., MoukhachevV., LavroukovA., KutepovS., QuartoR., MastrogiacomoM., and CanceddaR.Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng, 13, 5, 2007.
17.
KurodaR., IshidaK., MatsumotoT., AkisueT., FujiokaH., MizunoK., OhgushiH., WakitaniS., and KurosakaM.Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage, 15, 2, 2007.
18.
NejadnikH., HuiJ.H., Feng ChoongE.P., TaiB.C., and LeeE.H.Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med, 38, 6, 2010.
19.
WakitaniS., OkabeT., HoribeS., MitsuokaT., SaitoM., KoyamaT., NawataM., TenshoK., KatoH., UematsuK., KurodaR., KurosakaM., YoshiyaS., HattoriK., and OhgushiH.Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartialge repair in 41 patients with 45 joints followed up to 11 years and 5 months. J Tissue Eng Regen Med, 5, 2, 2011.
20.
KinnairdT., StabileE., BurnettM.S., LeeC.W., BarrS., FuchsS., and EpsteinS.E.Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res, 94, 678, 2004.
21.
HungS.C., PochampallyR.R., ChenS.C., HsuS.C., and ProckopD.J.Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells, 25, 2363, 2007.
22.
WangC.Y., YangH.B., HsuH.S., ChenL.L., TsaiC.C., TsaiK.S., YewT.L., KaoY.H., and HungS.C.Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats. J Tissue Eng Regen Med, 6, 7, 2012.
23.
NagayaN., FujiiT., IwaseT., OhgushiH., ItohT., UematsuM., YamagishiM., MoriH., KangawaK., and KitamuraS.Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol, 287, H2670, 2004.
24.
HuangN.F., LamA., FangQ., SieversR.E., LiS., and LeeR.J.Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med, 4, 527, 2009.
25.
OtsuK., DasS., HouserS.D., QuadriS.K., BhattacharyaS., and BhattacharyaJ.Concentration-dependant inhibition of angiogenesis by mesenchymal stem cells. Blood, 113, 18, 2009.
26.
McCarthyH.E., BaraJ.J., BrakspearK., SinghraoS.K., and ArcherC.W.The comparison of equine articular cartilage progenitor cells and bone marrow-derived stromal cells as potential cell sources for cartilage repair in the horse. Vet J, 192, 345, 2012.
27.
WrightK.T., El MasriW., OsmanA., RobertsS., ChamberlainG., AshtonB.A., and JohnsonW.E.Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A. Biochem Biophys Res Commun, 354, 559, 2007.
28.
McilroyM., O'RourkeM., McKeownS.R., Hirst, D.G., and Robson, T. Pericytes influence endothelial cell growth characterisics: Role of plasminogen activator inhibitor type 1 (PAI-1). Cardiovasc Res, 69, 207, 2006.
29.
KoernerJ., NesicD., RomeroJ.D., BrehmW., Mainil-VarletP., and GroganS.P.Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells, 24, 1613, 2006.
30.
WilliamsR., KhanI.M., RichardsonK., NelsonL., McCarthyH.E., AnalbelsiT., SinghraoS.K., DowthwaiteG.P., JonesR.E., BairdD.M., LewisH., RobertsS., ShawH.M., Dudhia, J., Fairclough, J., Briggs, T., and Archer, C.W. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS One, 5, e13246, 2010.
31.
JohnstoneB., HeringT.M., CaplanA.I., GoldbergA.M., and YooJ.U.In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res, 238, 265, 1998.
32.
BarryF., BoyntonR.E., LiuB., and MurphyJ.M.Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res, 268, 189, 2001.
33.
MurdochA.D., GradyL.M., AblettM.P., KatopodiT., MeadowsR.S., and HardinghamT.E.Chondrogenic differentiation of human bone marrow stem cells in transwell cultures: generation of scaffold-free cartilage. Stem Cells, 25, 2786, 2007.
34.
KimY.-J., KimH.-J., and ImG.-I.PTHrP promotes chondrogenesis and suppresses hypertrophy from both bone marrow-derived and adipose tissue-derived MSCs. Biochem Biophys Res Commun, 373, 104, 2008.
35.
GerberH.P., VuT.H., RyanA.M., KowalskiJ., WerbZ., and FerraraN.VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med, 5, 6, 1999.
36.
HirakiY., InoueH., IyamaK., KamizonoA., OchiaiM., ShukunamiC., IijimaS., SuzukiF., and KondoJ.Identification of chondromodulin I as a novel endothelial cell growth inhibitor. J Biol Chem, 272, 32419, 1997.
37.
HayamiT., ShukumaniC., MitsuiK., EndoN., TokunagaK., KondoJ., TakahashiH.E., and HirakiY.Specific loss of chondromodulin-I gene expression in chondrosarcoma and the supression of tumor angiogenesis and growth by its recombinant protein in vivo. FEBS Lett, 458, 436, 1999.
38.
StatonC.A., ReedM.W.R., and BrownN.J.A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol, 90, 195, 2009.
39.
PotapovaI.A., GaudetteG.R., BrinkP.R., RobinsonR.B., RosenM.R., CohenI.S., and DoroninS.V.Mesenchymal stromal cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells, 25, 1761, 2007.
40.
BosnakovskiD., MizunoM., KimG., IshiguroT., OkumuraM., IwanagaT., KadosawaT., and FujinagaT.Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells in pellet cultural system. Exp Hematol, 32, 502, 2004.
41.
DanišovicL., LesnýP., HavlasV., TeysslerP., SyrováZ., KopániM., FujerikováG., TrcT., SykováE., and JendelovÁP.Chondrogenic differentiation of human bone marrow and adipose tissue-derived mesenchymal stem cells. J Appl Biomed, 5, 139, 2007.
42.
GrellierM., BordenaveL., and AmédéeJ.Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol, 27, 562, 2009.
43.
HaradaS., NagyJ.A., SullivanK.A., ThomasK.A., EndoN., RodanG.A., and RodanS.B.Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest, 93, 2490, 1994.
44.
DeckersM.M., KarperienM., Van der BentC., YamashitaT., PapapoulosS.E., and LöwikC.W.Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology, 141, 1667, 2000.
45.
Mayr-WohlfartU., WaltenbergerJ., HausserH., KesslerS., GüntherK.P., DehioC., PuhlW., and BrennerR.E.Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone, 30, 472, 2002.
46.
SalehF.A., WhyteM., and GeneverP.G.Effects of endothelial cells on human mesenchymal stem cell activity in a three-dimensional in vitro model. Eur Cell Mater, 22, 242, 2011.
47.
HochA.I., BinderB.Y., GenetosD.C., and LeachJ.K.Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLos One, 7, e35579, 2012.
48.
KhouriR.K., KoudsiB., and ReddiH.Tissue transformation into bone in vivo: a potential practical application. J Am Med Assoc, 266, 14, 1991.
49.
KanczlerJ.M., GintyP.J., WhiteL., ClarkeN.M.P., HowdleS.M., ShakesheffK.M., and OreffoR.O.C.The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials, 31, 6, 2010.
50.
LiY., ChenJ., ChenX.G., WangL., GautamS.C., XuY.X., KatakowskiM., ZhangL.J., LuM., JanakiramanN., and ChoppM.Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology, 59, 514, 2002.
51.
NeuhuberB., HimesB.T., ShumskyJ.S., GalloG., and FischerI.Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res, 1035, 73, 2005.
52.
CriglerL., RobeyR.C., AsawachaicharnA., GauppD., and PhinneyD.G.Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol, 198, 54, 2006.
53.
CarmelietP.Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet, 4, 710, 2003.
54.
EichmannA., Le NobleF., AutieroM., and CarmelietP.Guidance of vascular and neural network formation. Curr Opin Neurobiol, 15, 108, 2005.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
